Olivera M. Andrejić

Dr. Olivera M. Andrejić

Clinical Centre Kragujevac, Serbia
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Olivera M. AndrejićOlivera M. Andrejić
Olivera M. Andrejić
Rada Milenko VučićRada Milenko Vučić
Rada Milenko Vučić
MPMilan Pavlovic
Milan Pavlovic
LMLana McClements
Lana McClements
DSDragana Stokanovic
Dragana Stokanovic
VNValentina N. Nikolic
Valentina N. Nikolic
Our study investigates association between Galectin-3 levels and adverse left ventricular remodelling (LVR) at six months. Fifty-seven patients following first acute myocardial infarction (AMI) were enrolled in this study and blood samples collected on day 1 from the femoral vein and artery, the right atrium near the coronary sinus and the aortic root, and on day 30, from the cubital vein. Patients with LVESV ≥20% at six months, were included in the LVR group. On day 1, Galectin-3 plasma levels in the femoral vein (10.34 ng/ml ± 3.81 vs 8.22 ng/ml ± 2.34, p = 0.01), and near coronary sinus (10.7 ng/ml ± 3.97 vs 8.41 ng/ml ± 2.56, p = 0.007) were higher in the LVR group. Positive correlations between Galectin-3 levels from aortic root and coronary sinus, aortic root and femoral vein, and coronary sinus and femoral vein, were observed in both groups. On day 30, Galectin-3 concentration in the cubital vein was an independent risk factor of LVR six months post-AMI, demonstrating 1.5-fold increased risk. Day-30 Galectin-3 also showed positive correlations with echocardiography parameters indicative of diastolic and systolic dysfunction. Determining Galectin-3 plasma concentration on day 30 following AMI could have beneficial prognostic value in predicting LVR.

14 February 2022 in Medicina
Verified
Journal Article
Open access
PDF file
BMBranka Mitic
Branka Mitic
AJAndriana Jovanovic
Andriana Jovanovic
VNValentina Nikola Nikolic
Valentina Nikola Nikolic
DSDragana Stokanović
Dragana Stokanović
Olivera M. AndrejićOlivera M. Andrejić
Olivera M. Andrejić
Stefan Desimir MomčilovićStefan Desimir Momčilović
Stefan Desimir Momčilović
Background and Objectives: Given the fact that galectin-3 has a predictive significance on the development of myocardial dysfunction after acute myocardial infarction, the aim of our study was to examine potential factors that could be important for the dynamics of the concentration of this biomarker in the early postinfarction period. Materials and Methods: This study included 89 patients with a diagnosis of stable angina pectoris (SAP) or the first non-ST elevation (NSTEMI) or ST-elevation (STEMI) myocardial infarction, who underwent percutaneous coronary intervention (PCI). The study group included 23 patients with the first NSTEMI and 42 patients with STEMI, while the control group consisted of 24 patients with SAP hospitalized for elective PCI without a previous MI. All patients had preserved left ventricular ejection fraction. Galectin-3 levels were determined on days 1, 5, and 30 after PCI. The significance of various independent variables as predictors of galectin-3 concentration was analyzed after a series of univariate linear regression modeling in a multivariate linear regression model. Results: The average patients’ age was 63.99 ± 9.13 years. Statistically significantly higher values of C-reactive protein were established in STEMI compared to SAP (p < 0.01) or NSTEMI (p < 0.001), whereas WBC count was significantly lower in SAP than in STEMI (p < 0.001) and NSTEMI (p < 0.01) group. Although there were no statistically significant differences in measured galectin-3 concentrations between the examined groups on days 1, 5, and 30 after PCI, HTA, triglyceride level, LA size, treatment with trimetazidine and long-acting nitrates, as well as percentage of LM stenosis and E/A ratio were identified as independent predictors of galectin-3 concentration. Conclusions: In the post-MI period, very early values of galectin-3 correlate mostly with atherosclerosis factors, while on day 30 this biomarker correlates with diastolic dysfunction and “announces” left ventricular remodeling.

31 October 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
Rada Milenko VučićRada Milenko Vučić
Rada Milenko Vučić
Olivera M. AndrejićOlivera M. Andrejić
Olivera M. Andrejić
DSDragana Stokanovic
Dragana Stokanovic
TJTatjana Jevtović-Stoimenov
Tatjana Jevtović-Stoimenov
LMLana McClements
Lana McClements
MPMilan Pavlovic
Milan Pavlovic
Background: Galectin-3 (Gal-3) is a biomarker involved in a wide range of diseases including cardiac remodeling following acute myocardial infarction (AMI). Identification of prognostic markers in patients with AMI can guide strategies towards improved survival and quality of life. Methods: Our study included 59 patients with AMI and a preserved ejection fraction. We determined the Gal-3 plasma concentration within 24 h of chest pain onset from the aortic root, femoral/radial artery, coronary sinus and cubital vein. Major adverse cardiovascular events (MACEs) were evaluated at six months follow-up. Results: MACE at six months post-AMI was recorded in 20 patients (34%). The Gal-3 plasma concentration from the aortic root and the femoral/radial artery were independent predictors of MACE at six months follow-up after the first AMI (OR 1.228; 95%CI: 1.011–1.491; p = 0.038; OR 3.438; 95%CI: 1.275–9.265; p = 0.015). ROC analysis identifies the Gal-3 plasma concentration from the aortic root as a better predictor of MACE or death (cut-off ≥ 10.86 ng/mL; AUC 0.858; 95%CI: 0.744–0.973; p < 0.001) than Gal-3 plasma concentration from the femoral/radial artery (cut-off ≥ 10.18 ng/mL; AUC 0.742; 95%CI: 0.596–0.888; p = 0.006). Conclusion: the Gal-3 plasma concentration in patients with AMI determined during coronary angiography, especially from the aortic root, within 24 h after chest pain onset is a valuable biomarker of prognosis at six months follow-up.

25 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Rada Milenko VučićRada Milenko Vučić
Rada Milenko Vučić
Olivera M. AndrejićOlivera M. Andrejić
Olivera M. Andrejić
DSDragana Stokanovic
Dragana Stokanovic
TJTatjana Jevtović-Stoimenov
Tatjana Jevtović-Stoimenov
LMLana McClements
Lana McClements
MPMilan Pavlovic
Milan Pavlovic
Background: Galectin-3 (Gal-3) is a biomarker involved in a wide range of diseases including cardiac remodeling following acute myocardial infarction (AMI). Identification of prognostic markers in patients with AMI can guide strategies towards improved survival and the quality of life. Methods: Our study included 59 patients with AMI and preserved ejection fraction. We determined the Gal-3 plasma concentration within 24 hours of chest pain onset from aortic root, femoral/radial artery, coronary sinus and cubital vein. Major adverse cardiovascular events (MACE) were evaluated at six months follow-up. Results: MACE at six months post-AMI was recorded in 20 patients (34%). The Gal-3 plasma concentration from aortic root and the femoral/radial artery were independent predictors of MACE at six months follow-up after the first AMI (OR 1.228; 95%CI: 1.011-1.491; p=0.038; OR 3.438; 95%CI: 1.275-9.265; p=0.015). ROC analysis identifies the Gal-3 plasma concentration from aortic root as a better predictor of MACE or death (cut-off >10.86 ng/ml; AUC 0.858; 95%CI: 0.744-0.973; p10.18 ng/ml; AUC 0.742; 95%CI: 0.596-0.888; p=0.006). Conclusion: The Gal-3 plasma concentration in patients with AMI determined during coronary angiography, especially from the aortic root, within 24 hours after chest pain onset is a valuable biomarker of prognosis at six months follow-up.

1 March 2022 in Serbian Journal of Experimental and Clinical Research
Verified
Journal Article
Open access
PDF file
Olivera M. AndrejićOlivera M. Andrejić
Olivera M. Andrejić
RVRada Vucic
Rada Vucic
VCVioleta Iric Cupic
Violeta Iric Cupic
GDGoran Davidovic
Goran Davidovic
Introduction: Acute intermittent porphyria (AIP) is the most common and the most severe form of acute hepatic porphyria. Case report: Patient, 39 years old, was admitted to the Emergency Department because of abdominal pain. Abdominal pain started 5 days before the admission. The diagnostic research in his hospital showed presence of a stone in the right kidney, and the patient was transported to the other Clinical Centre, where a common urine test showed: high values of delta - aminolevulinic acid and porphobilinogen. The patient was transported to our Clinical Centre. At the admission, abdominal pain decreased, but the patient had a hypertensive crisis with a headache, tearing eyes, swelling, anxiety.Common laboratory tests were in reference range, except creatinine, CRP, arterial blood gas analysis, urine test. The hypertensive crisis was treated by beta blockers and diuretics in maximal doses, but without a positive effect, so we decided to try with Glyceryl trinitrate intravenously. Control blood pressure was 170/100mmHg….130/80mmHg. Discussion: Porphyria can be a diagnostic problem, because one of the manifestations can be abdominal pain. Conclusions: Comorbidities can be critical in the therapy of life threating conditions.

1 January 2012 in PONS - medicinski casopis
Verified
Journal Article
Open access
PDF file
Olivera M. AndrejićOlivera M. Andrejić
Olivera M. Andrejić
Rada Milenko VučićRada Milenko Vučić
Rada Milenko Vučić
MČMaja Čolić
Maja Čolić
VZVladimir Zdravković
Vladimir Zdravković
Objective. Inflammation appears to be pivotal in all phases of atherosclerosis from the endothelial dysfunction to acute coronary syndromes. An important marker of inflammation is C-reactive protein (CRP). The sex hormones estrogen and testosterone have been shown to modify the inflammatory response by influencing cytokine expression in human macrophage cells. Method. Our retrospective study included 147 patients (73 patients with STEMI, 44 with NSTEMI) and 30 controls. Information about demographic characteristics, CRP values (at admission) we collected using clinical files. All results were carrying out using Student T test and binary logistic regression. P values =<0.05 were considered statistically significant. Results. CRP difference in 117 patients with acute myocardial infarction (73 patients with STEMI and 44 patients with NSTEMI) and 30 healthy individuals (controls) is statistically significant (p=0.001). CRP difference between male and female is statistically significant in patient with STEMI (25,14 ± 29,23 versus 13,16 ± 17,05, p =0,038), but not in NSTEMI patients. Observing CRP, gender and age in binary logistic regression, only CRP increases risk for acute myocardial infarction, OR=1,952. Conclusion. CRP value is higher in patients with acute myocardial infarction and shows gender difference, higher values are in women with STEMI.